CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Glaxo Smithkline Consumer Nig PLC Company Snapshot
Glaxo Smithkline Consumer Nig PLC operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Glaxo Smithkline Consumer Nig PLC with three other pharmaceutical manufacturers in Africa: Promopharm SA of Morocco (2016 sales of 529.79 million Moroccan Dirhams [US$56.43 million] ), Societe Adwya SA of Tunisia (84.65 million Dinar [US$34.23 million] ), and Unimed SA which is also based in Tunisia (64.86 million Dinar [US$26.23 million] ).

Sales Analysis. During the year ended December of 2016, sales at Glaxo Smithkline Consumer Nig PLC were 14.38 billion Naira (US$45.74 million). This is a sharp decrease of 53.0% versus 2015, when the company's sales were 30.63 billion Naira.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Glaxo Smithkline Consumer Nig PLC
  Stock Performance Chart for Glaxo Smithkline Consumer Nig PLC
 
  Stock Data: Recent Stock Performance:
  Current Price (10/13/2017): 21.00
(Figures in Naira)
1 Week 0.0%   13 Weeks -1.9%  
4 Weeks 5.0%   52 Weeks 14.2%  
 
Glaxo Smithkline Consumer Nig PLC Key Data:
  Ticker: GLAXOSMITH Country: Nigeria
  Exchanges: NIG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 14,384,785,000
(Year Ending Jan 2017).
Employees: 322
  Currency: Naira Market Cap: 25,113,396,000
  Fiscal Yr Ends: December Shares Outstanding: 1,195,876,000
  Share Type: Closely Held Shares: 444,444,784
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.